Eber C. Correa

Brasilia, DF, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Effects of hippotherapy on postural balance, functional mobility, self-perceived fatigue, and quality of life in people with relapsing-remitting multiple sclerosis: Secondary results of an exploratory clinical trial.

Effects of hippotherapy on postural balance, functional mobility, self-perceived fatigue, and quality of life in people with relapsing-remitting multiple sclerosis: Secondary results of an exploratory clinical trial.

Journal: Multiple sclerosis and related disorders

Published: October 27, 2020

Effect of hippotherapy on walking performance and gait parameters in people with multiple sclerosis.

Effect of hippotherapy on walking performance and gait parameters in people with multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: May 12, 2020

Late Onset of Neuromyelitis Optica Spectrum Disorders.

Late Onset of Neuromyelitis Optica Spectrum Disorders.

Journal: Neurology and therapy

Published: April 25, 2019

Clinical characteristics of 153 Brazilian patients with neuromyelitis optica spectrum disorder (NMOSD).

Clinical characteristics of 153 Brazilian patients with neuromyelitis optica spectrum disorder (NMOSD).

Journal: Multiple sclerosis and related disorders

Published: September 15, 2018

Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis.

Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis.

Journal: Arquivos de neuro-psiquiatria

Published: March 17, 2018

Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis.

Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis.

Journal: Arquivos de neuro-psiquiatria

Published: January 04, 2018

Real-life experience with fampridine (Fampyra®) for patients with multiple sclerosis and gait disorders.

Real-life experience with fampridine (Fampyra®) for patients with multiple sclerosis and gait disorders.

Journal: NeuroRehabilitation

Published: July 04, 2016

Alternatives for reducing relapse rate when switching from natalizumab to fingolimod in multiple sclerosis.

Alternatives for reducing relapse rate when switching from natalizumab to fingolimod in multiple sclerosis.

Journal: Expert review of clinical pharmacology

Published: January 23, 2016

Safety of switching from natalizumab straight into fingolimod in a group of JCV-positive patients with multiple sclerosis.

Safety of switching from natalizumab straight into fingolimod in a group of JCV-positive patients with multiple sclerosis.

Journal: Arquivos de neuro-psiquiatria

Published: January 13, 2016

We know how to prescribe natalizumab for multiple sclerosis, but do we know how to withdraw it?

We know how to prescribe natalizumab for multiple sclerosis, but do we know how to withdraw it?

Journal: Expert review of neurotherapeutics

Published: January 15, 2014

Multiple sclerosis starting before the age of 18 years: the Brazilian experience.

Multiple sclerosis starting before the age of 18 years: the Brazilian experience.

Journal: Arquivos de neuro-psiquiatria

Published: April 29, 2013

Multiple sclerosis in South America: month of birth in different latitudes does not seem to interfere with the prevalence or progression of the disease.

Multiple sclerosis in South America: month of birth in different latitudes does not seem to interfere with the prevalence or progression of the disease.

Journal: Arquivos de neuro-psiquiatria

Published: December 05, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026